Morten Baltzer Houlind

Morten Baltzer Houlind

Postdoc


Publication year:
All
31 - 33 out of 33Page size: 10
  1. 2024
  2. Published

    Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification

    Houlind, Morten Baltzer, Hansen, L., Iversen, E., Rasmussen, H. B., Larsen, J. B., Jørgensen, S., Dalhoff, Kim, Damkier, P., Walls, Anne Byriel, Vermehren, Charlotte, Andersen, T. R. H., Kallemose, T., Christrup, Lona Louring & Westergaard, N., 2024, In: Basic and Clinical Pharmacology and Toxicology. 134, 5, p. 756-763 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis

    Curovic, V. R., Tavenier, J., Ferreira-Divino, L. F., Poulsen, C. G., Houlind, Morten Baltzer, Pedersen, O. B., Urbak, L., Hansen, T. W., Sillesen, Henrik, Frimodt-Møller, M., Hvas, A. & Rossing, Peter, 2024, In: Journal of Diabetes and its Complications. 38, 1, 108654.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization

    Westergaard, N., Houlind, Morten Baltzer, Christrup, Lona Louring, Juul-Larsen, H. G., Strandhave, C. & Olesen, A. E., 2024, In: Basic and Clinical Pharmacology and Toxicology. 134, 4, p. 531-542

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 283951172